STOCK TITAN

Schedule 13G/A: T. Rowe Price holds 32,928,415 AVTR shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. filed Amendment No. 7 to Schedule 13G reporting beneficial ownership of 32,928,415 shares of Avantor, Inc. common stock, representing 4.8% of the class as of 09/30/2025.

The filer reports sole voting power over 32,838,902 shares and sole dispositive power over 32,928,415 shares, with no shared voting or dispositive power. The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/14/2025

FAQ

What stake in AVTR does T. Rowe Price report?

4.8% of Avantor’s common stock, with 32,928,415 shares beneficially owned.

How many AVTR shares does T. Rowe Price have voting power over?

Sole voting power over 32,838,902 shares and no shared voting power.

What is T. Rowe Price’s dispositive power over AVTR shares?

Sole dispositive power over 32,928,415 shares; no shared dispositive power.

What is the event date for this AVTR Schedule 13G/A?

The Date of Event is 09/30/2025.

Did T. Rowe Price indicate any intent to influence control of Avantor (AVTR)?

No. The filing certifies holdings are in the ordinary course and not to change or influence control.

What type of filer is T. Rowe Price Investment Management, Inc.?

It is classified as an investment adviser (IA).
Avantor

NYSE:AVTR

AVTR Rankings

AVTR Latest News

AVTR Latest SEC Filings

AVTR Stock Data

8.44B
657.57M
1.37%
106.68%
4.4%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR